Words To The Wise: Attorneys Analyze FDA’s Case Against Utah Medical
This article was originally published in The Gray Sheet
Executive Summary
An FDA legal official signaled that the agency's recent loss of a device manufacturing compliance case does not mean that the agency will stop going after firms with deficient quality controls - even in cases where there have been no adverse events or failures associated with the firm's products
You may also be interested in...
Utah Medical Seeks Reparations From FDA For Alleged FDA Misconduct
Utah Medical is considering whether to file a lawsuit against FDA after the Department of Health & Human Services denied its "administrative claim" seeking payments and other settlement actions based on alleged misconduct by FDA employees
Utah Medical Seeks Reparations From FDA For Alleged FDA Misconduct
Utah Medical is considering whether to file a lawsuit against FDA after the Department of Health & Human Services denied its "administrative claim" seeking payments and other settlement actions based on alleged misconduct by FDA employees
NuVasive Boosts Artificial Disc Development, Stock; OTC Index Rises 15%
NuVasive will use profits gained from a series of 510(k)-cleared spinal devices to fuel artificial disc and nucleus replacement development in 2006